In conclusion, furin offers an attractive therapeutic target to target airways dehydration in CF caused by loss of CFTR-mediated chloride secretion and the resulting unrestrained ENaC activity as well as other key aspects of the disease, including infective, inflammatory and remodelling processes. This evidence concerns the gene FURIN and cystic fibrosis.